Composition for treating infectious diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8461202
APP PUB NO 20100087690A1
SERIAL NO

12529626

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds of the general formula (I) or salts thereof, for use as a pharmaceutical composition for treating infectious diseases, especially for treating diseases caused by Helicobacter are disclosed. R1 is an H atom, an X atom or a CXmH3-m radical wherein each X can be the same or different and is a halogen selected from F, Cl, Br or I, and m is an integer between 1 and 3; R2 is an NO2 group, a COOR′ group or an SO3R′ group; R′ is a hydrogen (H) atom or a C1-C6 alkyl group; and n is an integer between 1 and 5.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSIDAD DE ZARAGOZAC/ PEDRO CERBUNA 12 ZARAGOZA 50009

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cremades, Casasin Nunilo Zaragoza, ES 4 21
Sancho, Sanz Javier Zaragoza, ES 6 43
Velazquez, Campoy Adrián Zaragoza, ES 3 21

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 11, 2024
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00